Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer
Bemis Company (NYSE: BMS) Delayed: 57.25 --0 (-0%)
Previous Close $57.25    52 Week High $54.19 
Open $68.29    52 Week Low $42.45 
Day High $57.25    P/E 28.06 
Day Low $57.25    EPS $2.04 
Volume 85,365       

Bristol-Myers Squibb (NYSE: BMY) Delayed: 55.53 +0.83 (1.52%)
Previous Close $54.70    52 Week High $77.12 
Open $55.39    52 Week Low $49.03 
Day High $55.94    P/E 36.06 
Day Low $54.96    EPS $1.54 
Volume 21,083,828       

(NYSE: RCUS) Delayed: 28.18 +0.95 (3.49%)
Previous Close $27.23    52 Week High $ 
Open $26.72    52 Week Low $ 
Day High $28.27    P/E N/A 
Day Low $26.72    EPS $ 
Volume 2,341,902